Evidence map›Paper›PMID 39329825›Full record

ArticleBiosensors2024

Development of a Modular miRNA-Responsive Biosensor for Organ-Specific Evaluation of Liver Injury.

Xinxin Zhang, Tingting Wang, Xiangqing Fan, Meixia Wang, Zhixi Duan, Fang He, Hong-Hui Wang, Zhihong Li

Abstract read
In one paragraph

Article in Biosensors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xinxin ZhangCollege of Biology, Hunan University, No. 27 Tianma Road, Yuelu District, Changsha 410082, China.
Tingting WangCollege of Biology, Hunan University, No. 27 Tianma Road, Yuelu District, Changsha 410082, China.
Xiangqing FanCollege of Biology, Hunan University, No. 27 Tianma Road, Yuelu District, Changsha 410082, China.
Meixia WangCollege of Biology, Hunan University, No. 27 Tianma Road, Yuelu District, Changsha 410082, China.
Zhixi DuanDepartment of Emergency Medicine, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
Fang HeCollege of Biology, Hunan University, No. 27 Tianma Road, Yuelu District, Changsha 410082, China.
Hong-Hui WangCollege of Biology, Hunan University, No. 27 Tianma Road, Yuelu District, Changsha 410082, China.ORCID 0000-0002-4420-9733
Zhihong LiDepartment of Trauma Center, The Second Xiangya Hospital of Central South University, Changsha 410011, China.

Funding

National Natural Science Foundation of China 22177030Natural Science Foundation of Hunan Province 2023JJ40814The Scientific Research Program of FuRong Laboratory 2023SK2104
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are increasingly being considered essential diagnostic biomarkers and therapeutic targets for multiple diseases. In recent years, researchers have emphasized the need to develop probes that can harness extracellular miRNAs as input signals for disease diagnostics. In this study, we introduce a novel miRNA-responsive biosensor (miR-RBS) designed to achieve highly sensitive and specific detection of miRNAs, with a particular focus on targeted organ-specific visualization. The miR-RBS employs a Y-structured triple-stranded DNA probe (Y-TSDP) that exhibits a fluorescence-quenched state under normal physiological conditions. The probe switches to an activated state with fluorescence signals in the presence of high miRNA concentrations, enabling rapid and accurate disease reporting. Moreover, the miR-RBS probe had a modular design, with a fluorescence-labeled strand equipped with a functional module that facilitates specific binding to organs that express high levels of the target receptors. This allowed the customization of miRNA detection and cell targeting using aptameric anchors. In a drug-induced liver injury model, the results demonstrate that the miR-RBS probe effectively visualized miR-122 levels, suggesting it has good potential for disease diagnosis and organ-specific imaging. Together, this innovative biosensor provides a versatile tool for the early detection and monitoring of diseases through miRNA-based biomarkers.

Indexed as

Biosensing TechniquesMicroRNAsAnimalsDNA ProbesHumansLiverDNA ProbesMicroRNAsbiomarkersdisease-associated microRNADNA nanotechnologyfluorescence probeliver injuryorgan-specific biosensing

Identifiers

PMID39329825
PMCPMC11430419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.